CommercialCoverageMedium impact
08.02.41, Datopotamab deruxtecan (Datroway®)
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Nov 3, 2025
We identified it
Jun 19, 2026
Summary
A new pharmacy policy has been established for Datopotamab deruxtecan (Datroway®), a specialty medication. This is a fresh policy that will likely establish coverage criteria, prior authorization requirements, or dispensing guidelines for this drug.
Action Required
By November 3, 2025: Billing team should review the full policy details at the provided URL to understand coverage criteria and any prior authorization requirements for Datopotamab deruxtecan (Datroway®). Update billing system with any new requirements once full policy details are available.